HomeTagsAscending Dose

Ascending Dose

Biotechnology

Moleculin Announces Completion of Third SAD Cohort in Phase 1a Clinical Trial of WP1122

PR Newswire - August 22, 2022

Moleculin Biotech, Inc., a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors and viruses, reported preliminary results...

Biotechnology

Moleculin Announces Completion of First Single Ascending Dose (SAD) Cohort in Phase 1a Clinical Trial of WP1122 in the UK

PR Newswire - June 18, 2022

Moleculin Biotech, Inc., a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors and viruses, reported preliminary results...